ZBH
Zimmer BiometBNYSE / Health Care Equipment & Services
Last Price
At close
2026-07-18
Current thesis
ZBH has primary-source support for an active innovation cycle and a defined April 28, 2026 event that could validate that the sales-force transition is manageable. If execution is clean, the shares have room to move toward and slightly above the packet's $102 median target.
Posture
Constructive
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta +0.3.
What can break
2026 guidance already leaves limited room for execution misses.
Momentum
31
Value
66
Sentiment
59
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $101.00 · Bull $108.00 · Bear $86.00
Data freshness
Prices
As of 2026-07-18
Fundamentals
As of 2026-07-17 • Vendor: Data Vendor v1
Scores
As of 2026-07-18 • Model: HYBRID_IC_RP
AI Memo
As of 2026-04-15 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-07-18
Investment thesis
As of 2026-07-18
Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Neutral
Target $95.94
Why
Momentum31 · Δ7d +12.4
Value66 · Δ7d +0.3
Sentiment59 · Δ7d -3.0
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Lead driver: Value · See fundamentals
Momentum
31
26% active weight
Current posture
7d trendImproving
Δ7d
+12.4
Δ21d
+5.9
Value
66
39% active weight
Current posture
7d trendFlat
Δ7d
+0.3
Δ21d
+0.9
Sentiment
59
34% active weight
Current posture
7d trendSoftening
Δ7d
-3.0
Δ21d
+1.2
Why this grade
Composite grade B. Momentum 31.4 / Value 66.1 / Sentiment 58.7
Fundamentals (TTM)As of 2026-07-17
Fundamentals (TTM)
As of 2026-07-17
Market Cap
$17.63B
Beta
0.62
Shares Out
193.46M
P/E (TTM)
22.9
P/S (TTM)
2.29
P/FCF (TTM)
19.53
Rev YoY
+9.3%
EPS YoY
+33.4%
Gross Margin
+61.5%
Op Margin
+16.6%
Net Debt
$7.16B
Current Ratio
1.73
As of 2026-07-18 • Updated nightlySource: Internal modelMethodology